Susan Nmn Ungar

Array ( [id] => 6096528 [patent_doc_number] => 20020052309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'METHOD OF TREATING ENDOTHELIAL INJURY' [patent_app_type] => new [patent_app_number] => 08/712358 [patent_app_country] => US [patent_app_date] => 1996-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4817 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052309.pdf [firstpage_image] =>[orig_patent_app_number] => 08712358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409299 [patent_doc_number] => 06172187 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'CD40 associated proteins' [patent_app_type] => 1 [patent_app_number] => 8/697610 [patent_app_country] => US [patent_app_date] => 1996-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16876 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/172/06172187.pdf [firstpage_image] =>[orig_patent_app_number] => 697610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3820660 [patent_doc_number] => 05730977 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-24 [patent_title] => 'Anti-VEGF human monoclonal antibody' [patent_app_type] => 1 [patent_app_number] => 8/698041 [patent_app_country] => US [patent_app_date] => 1996-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4796 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/730/05730977.pdf [firstpage_image] =>[orig_patent_app_number] => 698041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1413443 [patent_doc_number] => 06514498 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Modified/chimeric superantigens and their use' [patent_app_type] => B1 [patent_app_number] => 08/695692 [patent_app_country] => US [patent_app_date] => 1996-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10195 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514498.pdf [firstpage_image] =>[orig_patent_app_number] => 08695692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636986 [patent_doc_number] => 06379669 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Targeting of organs by immunoconjugates' [patent_app_type] => B1 [patent_app_number] => 08/691565 [patent_app_country] => US [patent_app_date] => 1996-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 11327 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/379/06379669.pdf [firstpage_image] =>[orig_patent_app_number] => 08691565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3625762 [patent_doc_number] => 05686250 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Antibodies to LGE.sub.2 -protein antigens' [patent_app_type] => 1 [patent_app_number] => 8/509180 [patent_app_country] => US [patent_app_date] => 1996-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 25 [patent_no_of_words] => 33612 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686250.pdf [firstpage_image] =>[orig_patent_app_number] => 509180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404095 [patent_doc_number] => 06171779 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'HMGI proteins in cancer' [patent_app_type] => 1 [patent_app_number] => 8/679529 [patent_app_country] => US [patent_app_date] => 1996-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 29 [patent_no_of_words] => 17860 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/171/06171779.pdf [firstpage_image] =>[orig_patent_app_number] => 679529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4186556 [patent_doc_number] => 06150500 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Activators of endothelial nitric oxide synthase' [patent_app_type] => 1 [patent_app_number] => 8/679006 [patent_app_country] => US [patent_app_date] => 1996-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14448 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150500.pdf [firstpage_image] =>[orig_patent_app_number] => 679006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3869386 [patent_doc_number] => 05763272 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Hybridoma for producing antibody for collagen I' [patent_app_type] => 1 [patent_app_number] => 8/678552 [patent_app_country] => US [patent_app_date] => 1996-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7448 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763272.pdf [firstpage_image] =>[orig_patent_app_number] => 678552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3920400 [patent_doc_number] => 05876691 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Antibody against carcionembryonic antigen (CEA)' [patent_app_type] => 1 [patent_app_number] => 8/652507 [patent_app_country] => US [patent_app_date] => 1996-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 13004 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876691.pdf [firstpage_image] =>[orig_patent_app_number] => 652507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619134 [patent_doc_number] => 05688653 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => '3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advanced glycosylation endproducts and methods of use therefor' [patent_app_type] => 1 [patent_app_number] => 8/673217 [patent_app_country] => US [patent_app_date] => 1996-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5349 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688653.pdf [firstpage_image] =>[orig_patent_app_number] => 673217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3786933 [patent_doc_number] => 05780032 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Method of using monoclonal antibodies to cytokeratin fragments' [patent_app_type] => 1 [patent_app_number] => 8/666835 [patent_app_country] => US [patent_app_date] => 1996-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 4168 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780032.pdf [firstpage_image] =>[orig_patent_app_number] => 666835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998277 [patent_doc_number] => 05858681 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Method for prognosis of prostate cancer' [patent_app_type] => 1 [patent_app_number] => 8/664857 [patent_app_country] => US [patent_app_date] => 1996-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 6713 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858681.pdf [firstpage_image] =>[orig_patent_app_number] => 664857 [rel_patent_id] =>[rel_patent_doc_number] =>)